Loading
A phase 2 trial in triple-negative breast cancer, run by Universitaire Ziekenhuizen KU Leuven, now recruiting.
LifEStyle Intervention to Enhance Efficacy of Neoadjuvant Therapy in Patients With Triple Negative Breast Cancer is a phase 2, randomised interventional study registered as NCT06831955 by Universitaire Ziekenhuizen KU Leuven, with a registry enrolment figure of 356 participants, started 2026-02-01 and due to reach its primary completion in 2028-09-01. Interventions recorded: Exercise Therapy; Fasting-Mimicking Diet; SOC. Conditions listed: Triple Negative Breast Cancer (TNBC), Early Setting. Triple-negative eligibility wording from the registry: "* The patient has a biopsy-confirmed diagnosis of stage II-III TNBC". Sites: Belgium. No results are recorded here; the registry entry is the source.
Shares Early triple-negative breast cancer, Triple-negative breast cancer trials open today (registry snapshot and UK sites) and the tag tnbc-deep-dive.
Shares Early triple-negative breast cancer, Triple-negative breast cancer trials open today (registry snapshot and UK sites) and the tag tnbc-deep-dive.
Shares Early triple-negative breast cancer, Triple-negative breast cancer trials open today (registry snapshot and UK sites) and the tag tnbc-deep-dive.
Shares Early triple-negative breast cancer, Triple-negative breast cancer trials open today (registry snapshot and UK sites) and the tag tnbc-deep-dive.
Shares Early triple-negative breast cancer, Triple-negative breast cancer trials open today (registry snapshot and UK sites) and the tag tnbc-deep-dive.
Shares Early triple-negative breast cancer, Triple-negative breast cancer trials open today (registry snapshot and UK sites) and the tag tnbc-deep-dive.
Shares Early triple-negative breast cancer, Triple-negative breast cancer trials open today (registry snapshot and UK sites) and the tag tnbc-deep-dive.
Shares Early triple-negative breast cancer, Triple-negative breast cancer trials open today (registry snapshot and UK sites) and the tag tnbc-deep-dive.